R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.
作者信息
Al-Sarayfi Diana, Meeuwes Frederik O, Durmaz Müjde, Issa Djamila E, Brouwer Rolf E, Beeker Aart, van Rhenen Anna, Mutsaers Pim G N J, Böhmer Lara H, van der Poel Marjolein W M, Te Boome Liane, van Meerten Tom, Chamuleau Martine E D, Zijlstra Josée M, Brink Mirian, Nijland Marcel
机构信息
Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Department of Hematology, Treant Hospital, Emmen, The Netherlands.
出版信息
Blood Cancer J. 2022 Sep 2;12(9):125. doi: 10.1038/s41408-022-00723-4.
Abstract
摘要
Zotero 插件